Indo Us Biotech per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
₹5.70₹6.54₹8.12
₹5.70₹6.54₹8.12
₹46.15₹46.15₹39.16
₹56.18₹55.08₹51.78
—−₹8.02−₹0.71
−₹9.22−₹9.22−₹0.71
—₹0.00₹0.25
2.02.02.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

INDOUS₹78.36

Indo Us Biotech Limited

· FMCG & Retail
₹ CrorePeersKOHINOORNATHBIOGENAGRITECHSARVESHWARSUKHJITSREGAALBSHSLGULPOLYMcap ₹157 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS8.126.545.70
Diluted EPS8.126.545.70
Book Value per Share39.1646.1546.15
Revenue per Share51.7855.0856.18
Cash Flow per Share-0.71-8.02—
Free Cash Flow per Share-0.71-9.22-9.22
Dividends per Share0.250.00—
Shares Outstanding (cr)2.02.02.0
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.